U.S. FDA panel narrowly backs Merck's at-home COVID-19 pill
Go back to U.S. FDA panel narrowly backs Merck's at-home COVID-19 pill| Merck & Co. (NYSE: MRK) | Delayed: 120.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.60 | 52 Week High | $65.46 | |||
| Open | $120.60 | 52 Week Low | $47.97 | |||
| Day High | $120.60 | P/E | 82.04 | |||
| Day Low | $120.60 | EPS | $1.47 | |||
| Volume | 3,522 | |||||
